Login
$SERA
$2.05 +$0.01 (0.49%) Close

Company Executives

$SERA Management Team

Dr. Kim Kamdar

Independent Chairman of the Board

Age 57
Compensation $200.0K USD
Sex Female

Mr. Robert Harrison

Chief Information Officer

Age 58
Compensation $1.908M USD
Sex Male

Mr. Peter Denardo

IR Contact Officer

Age -
Compensation -
Sex Male

Ms. Evguenia Lindgardt

President

Chief Executive Officer

Director

Age 51
Compensation $1.072M USD
Sex Female

Mr. Austin Aerts

Chief Financial Officer

Age 38
Compensation $1.036M USD
Sex Male

Dr. John Boniface

Chief Scientific Officer

Age 63
Compensation $431.3K USD
Sex Male

Mr. Benjamin Jackson

General Counsel

Age 46
Compensation $1.618M USD
Sex Male

Dr. Paul Kearney

Chief Data Officer

Age 57
Compensation $468.7K USD
Sex Male

Mr. Lee Anderson

Chief Commercial Officer

Age -
Compensation -
Sex Male

Dr. Tiffany Inglis

Chief Medical Officer

Age -
Compensation -
Sex Female
Directors
8
serving now
Independent
Not stated
the proxy does not say
Average tenure
9.1 years
from year joined
CEO also chairs the board
No
Kim Kamdar
Director Age On board Independent Committees Other public boards 2025 pay Source
Jeffrey T. Elliott
48 2025
1 year
Not stated
Audit Committee Compensation Committee
Quanterix Corporation $275,792
Kim Kamdar
58 2011
15 years
Not stated
Compensation Committee · Chair Nominating and Governance Committee
Seraphina Therapeutics, Truvian Sciences, Inc., Evofem Biosciences, Inc., Singular Genomics Systems Not stated
Sandra A. J. Lawrence
68 2021
5 years
Not stated
Audit Committee · Chair
Evergy, Inc. $99,908
Gregory C. Critchfield
74 2010
16 years
Not stated None stated None stated $84,908
Zhenya Lindgardt
52 2021
5 years
Not stated None stated None stated Paid as CEO
Joshua Phillips
59 2011
15 years
Not stated
Audit Committee Compensation Committee
None stated $97,408
Jane F. Barlow
65 2022
4 years
Not stated
Nominating and Governance Committee · Chair
None stated $93,408
Mansoor Raza Mirza
65 2014
12 years
Not stated
Nominating and Governance Committee
None stated $88,908

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

8 disclosed in the proxy filed Apr 24, 2026
Elevance Health
Listed under the heading Agreements with Stockholders
Amount not stated

Commercial Collaboration Agreement for use of the PreTRM test within Elevance Health's network, with minimum purchase and payment commitments for the first three years.

Elevance Health
Listed under the heading Agreements with Stockholders
Amount not stated

Laboratory Services Agreement for provision of PreTRM tests and related services during the PRIME study.

Baker Bros.
Principal stockholder
Amount not stated

Amended side letter giving Baker Bros. the right to nominate one Investor Designee to the board while it owns at least 19.9% of total voting power.

Certain holders of our capital stock
Holders of registrable shares under the Investors' Rights Agreement
Amount not stated

Fourth Amended and Restated Investors' Rights Agreement granting registration rights for resale of their shares.

Baker Bros.
Principal stockholder
Amount not stated
February 2025

Entities affiliated with Baker Bros. purchased Pre-Funded Warrants in the public offering to purchase 11,250,000 shares of Class A common stock at $3.9999 per warrant.

Chione Ltd.
Principal stockholder
Amount not stated

Chione Ltd. purchased 625,000 shares of Class A common stock in the public offering at $4.00 per share.

Real Endpoints LLC
Entity at which Jane F. Barlow, M.D., a member of our board of directors, is Executive Vice President and Chief Clinical Officer
$205,000

Consulting agreement (Statement of Work #1) for third-party payer engagement services; fees incurred under it.

Real Endpoints LLC
Entity at which Jane F. Barlow, M.D., a member of our board of directors, is Executive Vice President and Chief Clinical Officer
$30,000

Service agreement (Statement of Work #2) for pursuing third-party payer coverage for PreTRM; fees incurred before termination.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support